Veterinary Immunogenics

What Veterinary Immunogenics does

Veterinary Immunogenics Ltd, operating under the Plasvacc UK brand, is a privately held veterinary biological products manufacturer founded in 1992 and headquartered in Penrith, Cumbria, United Kingdom. The company specialises in hyperimmunised equine plasma biologics marketed under the Hypermune™ and Hypermune™-RE trademarks, which are cell-free plasma products with elevated IgG antibody levels derived from a Veterinary Medicines Directorate (VMD) approved donor herd. Plasma is collected using pheresing equipment and controls comparable to those used in human blood product collection, and each product label displays measured IgG content to guarantee higher antibody levels than non-hyperimmunised alternatives. The differentiated input is 100% single-source, never-blended donor plasma, providing full traceability from donor animal to patient.

The company also offers Canine & Feline Diagnostic Kits as an add-on product line, extending its reach from equine practitioners to small animal veterinarians. Its go-to-market is sales-led, with direct ordering via phone and website contact form rather than distributor or retail channels, and technical support is delivered by experienced veterinarians who use VIL products in their own practices. Veterinary Immunogenics operates in four countries — the UK, Australia, USA, and Chile — under the unified Plasvacc brand, and is a member of five major veterinary and equine professional associations (AAEP, AAEVT, AVH, VECCS, BEVA). Revenue is generated through one-time purchases of plasma biologics and diagnostic kits, with pricing not publicly disclosed.

Name

Veterinary Immunogenics

Legal name

Veterinary Immunogenics Ltd

Website

https://veterinaryimmunogenics.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

1–10 employees

Short description

Veterinary Immunogenics Ltd manufactures hyperimmunised equine plasma biologics (Hypermune™) and small animal diagnostic kits, selling directly to veterinarians across the UK, Australia, USA, and Chile under the Plasvacc brand.

Ownership category

akta.pro rank

Product category

Veterinary Biologics

SIC

Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Biologics & Immunotherapies (Non-vaccine) (HLAMAEAK)

akta.pro secondary industries

Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors) (HLAAAAAI), Equine Vaccines (HLAMAKAD)

Keywords

• Equine plasma products
• Veterinary biologicals
• Hyperimmunised plasma
• Veterinary diagnostics
• Animal plasma therapy

Headquarters

HQ city

Penrith

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Plasma Biologics Sales: Sale of hyperimmunised plasma products (Hypermune™, Hypermune™-RE) for veterinary use. Products are sold as one-time purchases for plasma therapy administration. Veterinary biologics company selling cell-free plasma for natural healing in animals.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Veterinary Immunogenics manufactures and supplies hyperimmunised equine blood plasma products (Hypermune™ and Hypermune™-RE) with high gamma globulin (IgG) content for natural antibody-based healing in animals. The company also offers canine and feline diagnostic kits. All plasma products are 100% traceable, single-source donor, never-blended, and collected from a Veterinary Medicines Directorate (VMD) approved herd.

Product overview

Veterinary Immunogenics is a veterinary biological products company specializing in hyperimmunized blood plasma products. The core offering consists of Hypermune™ and Hypermune™-RE equine plasma products, which are 100% traceable, single-source donor, cell-free plasma with high IgG antibody levels. The company also offers Canine & Feline Diagnostic Kits. All products are supported by plasma therapy methodology including collection processes, donor herd management, and purity/safety protocols.

Differentiator

Problem solved

Functional benefit

Brands

• Hypermune™: High gamma globulin (IgG), cell-free plasma biologics product for animals, particularly equine applications.
• Hypermune™-RE

Products and services

• Hypermune™ Products

Quantifiable outcome

• Higher IgG levels guaranteed compared to non-hyperimmunised plasma products

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered minor.

• American Association of Equine Practitioners (AAEP)minorOthersProfessional membership organization for equine veterinarians. Veterinary Immunogenics is a proud member, demonstrating industry engagement and alignment with equine veterinary standards.
• American Association of Equine Veterinary Technicians (AAEVT)minorOthersProfessional membership organization for equine veterinary technicians. Company membership demonstrates commitment to the broader equine veterinary professional community.
• Association of Veterinary Homeopathy (AVH)minorOthersProfessional organization for veterinary homeopathy practitioners. Company membership indicates alignment with holistic and complementary veterinary approaches.
• Veterinary Emergency and Critical Care Society (VECCS)minorOthersProfessional organization for veterinary emergency and critical care. Company membership supports engagement with specialists in urgent animal care settings.
• British Equine Veterinary Association (BEVA)minorOthersUK-based professional organization for equine veterinarians. Membership aligns the company with UK equine veterinary standards and professional community.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Elanco Animal Health: Major animal health company with equine and livestock biologic product lines. Broad incumbent — comparable end customers (veterinarians and equine owners) and an overlapping biologics portfolio, though much larger and broader in scope.
• Vetoquinol: Independent animal health company focused on veterinary pharmaceuticals and biologicals, with equine products. Broad incumbent — comparable in serving equine practitioners and offering biologic/therapeutic products, though diversified across species and geographies.
• Merck Animal Health (MSD Animal Health): Animal health division of Merck with equine vaccines, antiparasiticides, and biologics. Broad incumbent — same end customers (equine veterinarians) and an overlapping biologics portfolio, with vastly larger R&D and global commercial reach.
• Zoetis: Largest pure-play animal health company globally, with equine vaccines, parasiticides, and biologics. Broad incumbent — operates in the same equine and veterinary biologics space but at much greater scale and with a diversified portfolio rather than a single-product focus.
• Patterson Veterinary Supply: Major US veterinary distributor supplying pharmaceuticals, biologics, and equipment to equine and companion animal practices. Broad incumbent — serves as a potential distribution channel for veterinary biologics like Hypermune™ and competes indirectly by aggregating competing products.
• Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals company with a meaningful equine and companion-animal therapeutics portfolio. Broad incumbent — shares Veterinary Immunogenics' specialty veterinary therapeutics positioning and direct-to-veterinarian GTM motion, but at far greater scale across multiple therapeutic categories.
• IDEXX Laboratories: Leading veterinary diagnostics company whose in-clinic diagnostic kits overlap with Veterinary Immunogenics' canine and feline diagnostic kit offering. Broad incumbent — comparable in veterinary diagnostic delivery but operates at global scale across many modalities.

Emerging players

• VetStem Biopharma: Veterinary regenerative medicine company providing autologous stem cell therapies primarily for equine and canine patients. Emerging player — comparable specialty veterinary biologics business serving equine practices, though using cellular rather than plasma-based therapy.
• Torigen Pharmaceuticals: Veterinary cancer immunotherapy company offering autologous and biologic treatment products sold through veterinary practices. Emerging player — comparable specialty-veterinary biologic positioning and direct-to-veterinarian sales model, though focused on oncology rather than plasma-based antibody therapy.

Direct peers

• Lake Immunogenics: US-based producer of hyperimmune plasma products for animals (including equine), using single-donor and immunised donor protocols. Direct peer — same core product category (hyperimmune plasma biologics), same equine and broader animal-health customer base, and similar regulatory-driven manufacturing model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/702528898264429
• LinkedInlinkedin.com/company/veterinary-immunogenics-ltd

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Veterinary Immunogenics